v3.26.1
Statements of Redeemable Convertible Preferred Stock and Stockholders' Equity (Deficit) - USD ($)
$ in Thousands
Total
Series Seed [Member]
Series A [Member]
Series B [Member]
Series C [Member]
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Accumulated Other Comprehensive Income
Beginning balance, Temporary equity at Dec. 31, 2023   $ 435 $ 6,179 $ 580 $ 68,773        
Beginning Balance at Dec. 31, 2023 $ (34,473)         $ 1 $ 6,473 $ (41,221) $ 274
Beginning balance, Temporary equity, shares at Dec. 31, 2023   295,467 3,655,374 301,119 47,153,680        
Beginning Balance, shares at Dec. 31, 2023           249,476      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense 3,090           3,090    
Unrealized gain (loss) on marketable securities (163)               (163)
Issuance of redeemable convertible series C preferred stock, net of issuance costs         $ 38,292        
Issuance of redeemable convertible series C preferred stock, net of issuance costs (shares)         26,666,666        
Shares issued upon exercise of warrants $ 3           3    
Issuance of common stock upon initial public offering, net of issuance costs, Shares 253         253      
Shares issued upon exercise of options $ 20           20    
Shares issued upon exercise of option, shares           493      
Issuance of common stock for services $ 71           71    
Issuance of common stock for services, shares 1,433         1,433      
Net Income (Loss) $ (63,102)             (63,102)  
Ending Balance at Dec. 31, 2024 (94,554)         $ 1 9,657 (104,323) 111
Ending balance, Temporary equity at Dec. 31, 2024 $ 114,259 $ 435 $ 6,179 $ 580 $ 107,065        
Ending Balance, shares at Dec. 31, 2024           251,655      
Ending balance, Temporary equity, shares at Dec. 31, 2024 78,071,000 295,467 3,655,374 301,119 73,820,346        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Stock-based compensation expense $ 4,191           4,191    
Unrealized gain (loss) on marketable securities 57               57
Issuance of common stock upon initial public offering, net of issuance costs $ 302,315         $ 2 302,313    
Issuance of common stock upon initial public offering, net of issuance costs, Shares 464         21,850,000      
Shares issued upon exercise of option, shares 6,000         6,383      
Temporary Equity, Conversion of preferred stock to common stock   $ (435) $ (6,179) $ (580) $ (107,065)        
Temporary Equity, Conversion of preferred stock to common stock, shares   (295,467) (3,655,374) (301,119) (73,820,346)        
Conversion of preferred stock to common stock $ 114,259           114,259    
Conversion of preferred stock to common stock, shares           3,191,334      
Shares issued upon exercise of options and warrants 247           247    
Net Income (Loss) (25,205)             (25,205)  
Ending Balance at Dec. 31, 2025 $ 301,310         $ 3 $ 430,667 $ (129,528) $ 168
Ending balance, Temporary equity at Dec. 31, 2025   $ 0 $ 0 $ 0 $ 0        
Ending Balance, shares at Dec. 31, 2025           25,299,372      
Ending balance, Temporary equity, shares at Dec. 31, 2025   0 0 0 0